Aureobasidium pullulans, IgE, Serum
Use
This test is used for establishing a diagnosis of an allergy to Aureobasidium pullulans and defining the allergen responsible for eliciting signs and symptoms. It also helps in identifying allergens responsible for allergic response and/or anaphylactic episode, confirming sensitization prior to beginning immunotherapy, and investigating the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens. Testing for IgE antibodies is not useful in patients previously treated with immunotherapy to determine if residual clinical sensitivity exists or in patients where the medical management does not depend upon identification of allergen specificity.
Special Instructions
Not provided.
Limitations
Some individuals with clinically insignificant sensitivity to allergens may have measurable levels of IgE antibodies in serum. Test results must be interpreted in the clinical context. False-positive results for IgE antibodies may occur in patients with markedly elevated serum IgE (>2500 kU/L) due to nonspecific binding to allergen solid phases.
FDA ApprovedNew York Approved
Methodology
Immunoassay (FEIA)
Biomarkers
Aureobasidium pullulans IgE
Analyte
LOINC Codes
- 6029-3 - A pullulans IgE Qn
- 6029-3 - A pullulans IgE Qn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL per 5 allergens
Minimum Volume
0.3 mL
Container
Preferred: Serum gel tube, Acceptable: Red top tube
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
Gross hemolysis: OK; Gross lipemia: OK
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |